The study showed in a placebo-controlled crossover design that 4-week treatment with β2-adrenergic agonist clenbuterol enhances insulin-stimulated glucose uptake in skeletal muscle but not brown adipose tissue in individuals with obesity.
- Pip M. G. Van Lier
- Tineke van de Weijer
- Joris Hoeks
